Health Catalyst (HCAT): CEO bought ~$105K

~$105K

Approx. value · 59K sh @ $1.79

2.86M

Holds after · shares reported

Traded

Sep 14, 2026

Filed

Sep 17, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 31, 2026Company filing · Form 8-K · Agreement ended, Acquisition or saleCompleted buying or selling a business or assets, and ended an important agreement (and 2 more items)“On July 31, 2026, Health Catalyst completed the previously announced divestiture of all of the equity interests of VitalWare, LLC, through which Health Catalyst conducted its VitalWare business (“VitalWare”), to Med-Metrix, LLC (the “Buyer”) pursuant to that certain Unit Purchase Agreement (the “Purchase Agreement”), dated as of June 4, 2026, between Health Catalyst and the Buyer (the “Disposition”).”
2. Sep 4, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 4, 2026, the Board of Directors (the Board) of Health Catalyst, Inc. (the Company) appointed Simeon Kohl to succeed Ben Albert as the Company’s Chief Executive Officer, President, principal executive officer and principal operating officer and, upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the Nominating Committee), as a member of the Board as a Class III…”
3. Sep 11, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 11, 2026, Tami Reller was appointed to the Board, following the recommendation of the Nominating and Corporate Governance Committee of the Board (the Nominating Committee), to serve as a Class III director until her successor is duly elected and qualified, or until her earlier resignation, death or removal.”
4. Sep 14, 2026 · this disclosureInsider · First insider buy since Feb 2024CEO purchased ~$105K of HCAT shares in the open market

What came next

1. Nov 5, 2026Company filing · Form 8-K · ResultsReported its results
2. Nov 11, 2026InsiderOfficer sold ~$100K of HCAT shares in the open market
3. Nov 12, 2026InsiderOfficer sold ~$41K of HCAT shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Health Catalyst

For Health Catalyst, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HCAT page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Health Catalyst

• SEC Form 4Nov 13, 2026
• SEC Form 4Nov 13, 2026
• SEC Form 144Nov 12, 2026
• SEC Form 144Nov 11, 2026
• SEC Form 4Dec 10, 2025
• SEC Form 4Dec 10, 2025

Everything OQRO holds on this company is on its HCAT page.